Company Overview and News

16
UPL / Ultra Petroleum Corp. 8-K (Current Report)

2018-06-14 sec.gov
upl-8k_20180608.htm UNITED STATES
UPL

2
Ultra Petroleum (UPL) Down 2.5% Since Earnings Report: Can It Rebound?

2018-06-11 zacks
It has been about a month since the last earnings report for Ultra Petroleum Corp. (UPL - Free Report) . Shares have lost about 2.5% in that time frame.
HAWLN UPL HSC HAWLM HAWLL HAWLI UPLMQ HAWEL HAWEN HAWEM

21
Adversity Is Bitter, But Its Uses May Be Sweet

2018-06-05 seekingalpha
CORR has become a battle-tested REIT that is now better prepared to scale into a safer investment platform.
HIFR UPL XOM LMRK MS.PRE EEXXQ MS.PRF MS.PRG MS.PRA EXXI CANIF EGC EXXIQ MS.PRI MS.PRK EXIXQ ZEE UPLMQ MS HASI

11
UPL / Ultra Petroleum Corp. 8-K (Current Report)

2018-06-01 sec.gov
upl-8k_20180531.htm UNITED STATES
UPL

6
How New Sanctions on Iran Could Affect Crude Oil Prices

2018-05-30 marketrealist
On May 8, President Trump announced that the United States is exiting the Iran nuclear pact. Trump now plans to impose new sanctions on Iran. On May 21, US Secretary of State Mike Pompeo announced a list of demands for Iran. The demands are a prerequisite for any new agreement. He highlighted that all uranium enrichment activity must stop. Pompeo also said that all support activities for militants in the Middle East should stop.
UPL CVI UPLMQ

125
Four Reasons Why Natural Gas Prices Could Touch $3 Shortly

2018-05-30 zacks
Over the past few weeks, natural gas prices have risen to levels not seen in almost four months, reflecting a steady, albeit slow, ascent, after being range bound since late January. A confluence of factors could fuel the commodity's march to the psychologically important $3 level this summer.
ECR WFCNP UPL CHKVP CRK WFC.PRL WFC.PRJ CHKDH CHKVZ AR CHKDG WFC.PRT CHKDJ WFC.PRR WFC.PRQ CHKDP WFC.PRP WFC.PRO WFC.PRN GPOR WFC.PRY CHK.PRD WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS CKRGZ CHKWZ CHK CHK.WI UPLMQ

5
Top 3 Crude Oil Producers Impact Oil Futures

2018-05-29 marketrealist
On May 25, Saudi Arabia and Russia’s energy ministers said that the ongoing supply cuts could be eased. As a result, WTI crude oil futures dropped 4% to $67.88 per barrel on May 25.
CRC UPL LPI UPLMQ

37
MDC Partners price target halved to $6 from $12 at RBC Capital Markets

2018-05-18 marketwatch
MDC Partners to Present at the 46th Annual J.P. Morgan Global Technology, Media and Communications Conference
WFC WFCNP WFC.WS UPL DB ECOL WFC.PRL BATS WFC.PRJ 4162 WFC.PRT PZN WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN UPLMQ MDCA WFC.PRY WFC.PRX WFC.PRW WFC.PRV LAUR

1
US Dollar Index Is near a 5-Month High

2018-05-16 marketrealist
The US Dollar Index rose ~0.7% to 93.2 on May 15—the highest level since December 26, 2017. June WTI oil futures increased ~0.5% on May 15. The strong US Dollar Index restricted the upside for oil prices during this period.
UPL UPLMQ

14
Ultra Petroleum (UPL) Soars: Stock Adds 11.1% in Session

2018-05-16 zacks
Ultra Petroleum Corp. (UPL - Free Report) was a big mover last session, as the company saw its shares rise more than 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now down 36.7% in the past one-month time frame.
BL CCMP UPL UPLMQ BCEI

97
Coca-Cola, Snap Dive into Tuesday’s 52-Week Low Club

2018-05-15 247wallst
May 15, 2018: Here are four stocks trading with heavy volume among 97 equities making new 52-week lows in Tuesday’s session. On the NYSE decliners led advancers by about 1.94 to 1 and on the Nasdaq, decliners led advancers by about 1.12 to 1.
UPL KO UPLMQ SNAP MO UPL

27
Is the Options Market Predicting a Spike in Ultra Petroleum (UPL) Stock?

2018-05-15 zacks
Investors in Ultra Petroleum Corp. (UPL - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the May 18, 2018 $5 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other.
IPAR UPL DISCB DISCA BYSI UPLMQ DISCK GIII DISC

21
Symantec, Helios and Matheson Sink into Friday’s 52-Week Low Club

2018-05-11 247wallst
May 11, 2018: Here are four stocks trading with heavy volume among 67 equities making new 52-week lows in Friday’s session. On the NYSE advancers led decliners by about 1.12 to 1 and on the Nasdaq, advancers led decliners by about 1.13 to 1.
VIVMD SYMC UPL VIVE HMNY UPLMQ VIVMF

0
Ultra Petroleum Corp's (UPL) CEO Bradley Johnson on Q1 2018 Results - Earnings Call Transcript

2018-05-10 seekingalpha
Good day, everyone, and welcome to today's Ultra Petroleum Corp. First Quarter 2018 Earnings Conference Call. [Operator Instructions]. Please note this call is being recorded.
UPL UPLMQ

12
Nuance, Helios and Matheson Stumble into Thursday’s 52-Week Low Club

2018-05-10 247wallst
May 10, 2018: Here are four stocks trading with heavy volume among 56 equities making new 52-week lows in Thursday’s session. On the NYSE advancers led decliners by about 2.34 to 1 and on the Nasdaq, advancers led decliners by about 1.5 to 1.
UPL HMNY NUAN UPLMQ LB

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to UPL / Ultra Petroleum Corp. on message board site Silicon Investor.

I need to quintuple $20,000 Ultra Petroleum (UPL)
Financialsense (FSO) - Jim Puplava forum Ultra Petroleum Corp (UPL)
Duplicate SCS Solars Computing Systems (Duplicate)
Making Couplets for Fun Unwired Planet (www.uplanet.com)
BFLYand XCMC will zoom in next couple of days A COUPLE BIG MOVERS!!!
CUSIP: 903914208